AXT (AXTI) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue was $23.6M, up 36.2% year-over-year from $17.4M, driven by strong demand for GaAs, InP, and Ge substrates, as well as refined gallium and pBN crucibles.

• Gross profit rose 204.5% to $5.7M, with gross margin improving to 24.0% from 10.7% in Q3 2023 due to higher unit volume and favorable product mix.

• Net loss attributable to the company narrowed to $2.9M ($0.07/share), compared to $5.8M ($0.14/share) in Q3 2023, reflecting improved operating performance.

• Indium phosphide demand remained strong, driven by data center and AI applications, while Gallium Arsenide saw a pullback after strong Q2 growth.

• The company is optimistic about growth and expansion in 2025, especially in data center, HBT for wireless handsets, and raw material businesses.

Financial highlights

• Q3 2024 revenue was $23.6M, down from $27.9M in Q2 2024 but up from $17.4M in Q3 2023.

• Non-GAAP gross margin was 24.3% in Q3 2024, up from 11.3% in Q3 2023; GAAP gross margin was 24.0%.

• Non-GAAP net loss was $2.1M ($0.05/share), compared to $0.8M ($0.02/share) in Q2 2024; GAAP net loss was $2.9M ($0.07/share).

• Cash and equivalents decreased to $38.8M as of September 30, 2024, down from $50.1M at year-end 2023.

• Short-term loans stood at $54.1M, with an additional $6.4M in long-term loans.

Outlook and guidance

• Q4 2024 revenue expected between $23.0M and $25.0M, with growth in indium phosphide and raw materials offset by further decline in germanium.

• Non-GAAP net loss projected at $0.03–$0.05/share; GAAP net loss at $0.05–$0.07/share; share count ~43.1M.

• Management believes it has adequate cash and investments to meet operating needs and capital expenditures over the next 12 months.

• Anticipates healthy gross margin performance and positions for growth in 2025, especially in strategic business segments.

• Expects new order momentum in indium phosphide substrates for AI-related photodetector applications.